Peter A. Sillevis Smitt

3.0k citations

33 papers · 1.2k indexed · h-index 17

Neurology top 2%
Molecular Biology
Genetics top 5%
Cellular and Molecular Neuroscience top 10%
Cancer Research

Co-authors: Johan M. Kros Martin J. van den Bent Geoffrey T. Manley J. B. Posner Theo M. Luider Pim J. French Ivar Siccama Wilfried J. Graveland
Topics: Autoimmune Neurological Disorders and Treatments (13 papers)Peripheral Neuropathies and Disorders (8 papers)Glioma Diagnosis and Treatment (5 papers)
Cited by: Genetics Neurology Cancer Research
Journals: PLoS ONE Neurology Cancer
Partner nations: Netherlands United States Belgium

In The Last Decade

Peter A. Sillevis Smitt

33 papers receiving 1.2k citations

Peers

Countries citing papers authored by Peter A. Sillevis Smitt

Since Specialization

Citations

This map shows the geographic impact of Peter A. Sillevis Smitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Sillevis Smitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Sillevis Smitt more than expected).

Fields of papers citing papers by Peter A. Sillevis Smitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Sillevis Smitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Sillevis Smitt. The network helps show where Peter A. Sillevis Smitt may publish in the future.

Co-authorship network of co-authors of Peter A. Sillevis Smitt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Sillevis Smitt. A scholar is included among the top collaborators of Peter A. Sillevis Smitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Sillevis Smitt. Peter A. Sillevis Smitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical impact and safety of brain biopsy in unexplained central nervous system disorders: a real‐world cohort study 2025 ·Annals of Clinical and Translational Neurology ·(unknown),(unknown),Juna M. de Vries,Ide Smets,Robert M. Verdijk,(unknown),(unknown),(unknown),(unknown),Marjolein Geurts,Jacoline E. C. Bromberg,Corine H. GeurtsvanKessel,Peter A. Sillevis Smitt,Rutger K. Balvers,Maarten J. Titulaer	1
2	Cognition and health-related quality of life in long-term survivors of high-grade glioma: an interactive perspective from patient and caregiver 2024 ·Acta Neurochirurgica ·Jochem K. H. Spoor,(unknown),(unknown),(unknown),Clemens M.F. Dirven,Peter A. Sillevis Smitt,Martin J. van den Bent,Sieger Leenstra,Djaina Satoer	2
3	Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas 2015 ·Neuro-Oncology ·Martin J. van den Bent,Ya Gao,Melissa Kerkhof,Johan M. Kros,Thierry Gorlia,(unknown),(unknown),Sjoerd G. van Duinen,Peter A. Sillevis Smitt,Martin Taphoorn,Pim J. French	126
4	A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes 2014 ·Neuro-Oncology ·(unknown),Teun van Gelder,Jacoline E. C. Bromberg,Marieke T. de Graaf,Jan W. Gratama,Marco W.J. Schreurs,Herbert Hooijkaas,Peter A. Sillevis Smitt	19
5	Psychiatric phenomena as initial manifestation of encephalitis by anti‐NMDAR antibodies 2012 ·Acta Neuropsychiatrica ·(unknown),Esther de Graaff,(unknown),Esther Hulsenboom,Robert M. Verdijk,Kathelijne M. Koorengevel,Martijn M. VanDuijn,Herbert Hooijkaas,Casper C. Hoogenraad,Peter A. Sillevis Smitt	32
6	Absence of Common Somatic Alterations in Genes on 1p and 19q in Oligodendrogliomas 2011 ·PLoS ONE ·Linda B.C. Bralten,(unknown),Christel Kockx,(unknown),Casper C. Hoogenraad,Johan M. Kros,Michael Moorhouse,Peter A. Sillevis Smitt,Peter J. van der Spek,Wilfred F. J. van IJcken,Andrew Stubbs,Pim J. French	9
7	Contamination of synthetic HuD protein spanning peptide pools with a CMV‐encoded peptide 2008 ·Cytometry Part A ·Marieke T. de Graaf,(unknown),Peter C. Burgers,Theo M. Luider,Jaco Kraan,Peter A. Sillevis Smitt,Jan W. Gratama	8
8	Exon Expression Arrays as a Tool to Identify New Cancer Genes 2008 ·PLoS ONE ·Mieke Schutte,Fons Elstrodt,Linda B.C. Bralten,Jord H.A. Nagel,(unknown),Antoinette Hollestelle,(unknown),Marijke Wasielewski,Justine Peeters,Peter J. van der Spek,Peter A. Sillevis Smitt,Pim J. French	10
9	Identification of Differentially Regulated Splice Variants and Novel Exons in Glial Brain Tumors Using Exon Expression Arrays 2007 ·Cancer Research ·Pim J. French,Justine Peeters,(unknown),(unknown),Ivar Siccama,Martin J. van den Bent,Theo M. Luider,Johan M. Kros,Peter J. van der Spek,Peter A. Sillevis Smitt	70
10	No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies 2007 ·Cancer Immunology Immunotherapy ·(unknown),Georges M. G. M. Verjans,Yvette van Norden,(unknown),Jaco Kraan,Herbert Hooijkaas,Kees Sintnicolaas,Jan W. Gratama,Peter A. Sillevis Smitt	11
11	Eye movements as a marker for cerebellar damage in paraneoplastic neurological syndromes 2007 ·Parkinsonism & Related Disorders ·(unknown),Maarten A. Frens,Peter A. Sillevis Smitt,Jos N. van der Geest	5
12	The impact of impurities in synthetic peptides on the outcome of T‐cell stimulation assays 2007 ·Rapid Communications in Mass Spectrometry ·(unknown),Jan W. Gratama,Peter A. Sillevis Smitt,Georges M. G. M. Verjans,Jaco Kraan,Theo M. Luider,Peter C. Burgers	17
13	Managing Paraneoplastic Neurological Disorders 2006 ·The Oncologist ·(unknown),Peter A. Sillevis Smitt	109
14	Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas 2005 ·Cancer Research ·Pim J. French,Sigrid Swagemakers,Jord H.A. Nagel,Mathilde C.M. Kouwenhoven,Eric Brouwer,Peter J. van der Spek,Theo M. Luider,Johan M. Kros,Martin J. van den Bent,Peter A. Sillevis Smitt	99
15	MALDI-TOF Mass Spectrometry Analysis of Cerebrospinal Fluid Tryptic Peptide Profiles to Diagnose Leptomeningeal Metastases in Patients with Breast Cancer 2005 ·Molecular & Cellular Proteomics ·Lennard J. M. Dekker,Willem Boogerd,Guenther Stockhammer,(unknown),Ivar Siccama,Ping‐Pin Zheng,Johannes M.G. Bonfrèr,Jan J.G.M. Verschuuren,Guido Jenster,Marcel M. Verbeek,Theo M. Luider,Peter A. Sillevis Smitt	66
16	A new method to analyze matrix‐assisted laser desorption/ionization time‐of‐flight peptide profiling mass spectra 2005 ·Rapid Communications in Mass Spectrometry ·Lennard J. M. Dekker,(unknown),Ivar Siccama,Guido Jenster,Peter A. Sillevis Smitt,Theo M. Luider	36
17	Resolution of EBV⁺ CNS lymphoma with appearance of CSF EBV‐specific T cells 2005 ·Annals of Neurology ·(unknown),(unknown),Martin J. van den Bent,Mars B. van ’t Veer,G J van Doornum,Jan J. Cornelissen,Peter A. Sillevis Smitt,Jan W. Gratama	4
18	Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features 2003 ·Cancer ·Martin J. van den Bent,Leendert H. J. Looijenga,Karin P.S. Langenberg,Winand N.M. Dinjens,Wilfried J. Graveland,(unknown),Peter A. Sillevis Smitt,Robert B. Jenkins,Johan M. Kros	160
19	Mechanisms underlying cerebellar motor deficits due to mGluR1‐autoantibodies 2002 ·Annals of Neurology ·Michiel Coesmans,Peter A. Sillevis Smitt,David J. Linden,Ryuichi Shigemoto,Tomoo Hirano,Yoshinori Yamakawa,Adriaan M. van Alphen,(unknown),Jos N. van der Geest,Johan M. Kros,Sandrine Gaillard,Maarten A. Frens,Chris I. De Zeeuw	138
20	[Transdermal opioid administration: the pain plaster]. 1997 ·PubMed ·Charles J. Vecht,Peter A. Sillevis Smitt	1

About Peter A. Sillevis Smitt

Peter A. Sillevis Smitt is a scholar working on Neurology, Genetics and Anesthesiology and Pain Medicine, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Autoimmune Neurological Disorders and Treatments (13 papers), Peripheral Neuropathies and Disorders (8 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Genetics (343 citations), Neurology (489 citations) and Cancer Research (159 citations). Peter A. Sillevis Smitt has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Johan M. Kros, Martin J. van den Bent, Geoffrey T. Manley, J. B. Posner, Theo M. Luider, Pim J. French, Ivar Siccama, Wilfried J. Graveland, Robert B. Jenkins and Leendert H. J. Looijenga. Their work appears in journals such as PLoS ONE, Neurology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact